Peer-reviewedCC BYBiomedicines
The Gut–Kidney Axis in Chronic Kidney Disease: Microbial Dysbiosis, Host–Microbial Metabolism, and Emerging Therapeutic Strategies
- 1Department of Nephrology, Ghent University Hospital, 9000 Ghent, Belgium; (L.V.); (T.M.); (C.D.)
Related
- From microbial dysbiosis to putative epigenetic locking: a hypothesis-driven framework for the pathogenesis and future therapeutic perspectives of gastric intestinal metaplasia.
- The gut-microbiota-endometriosis axis: a review of immune regulation, microbial dysbiosis, host transcriptomics, probiotic intervention, and dietary influences
- Osteoimmuno-microbial feedback loops in medication-related osteonecrosis of the jaw: from dysbiosis to persistent structural osteonecrosis
- Longitudinal Multi-omics Reveals Persistent Gut Microbial and Metabolic Dysbiosis Following Anti-Tuberculosis Therapy
- Microbial Dysbiosis, Infection, and Immunometabolic Signaling in Polyendocrine Metabolic Ovarian Syndrome (Formerly PCOS).
BibTeX
@article{vijverman2026gutkidney,
title = {{The Gut–Kidney Axis in Chronic Kidney Disease: Microbial Dysbiosis, Host–Microbial Metabolism, and Emerging Therapeutic Strategies}},
author = {Louise Vijverman and Too Maddalena and Charlotte Delrue and Marijn M. Speeckaert},
journal = {Biomedicines},
year = {2026},
month = sep,
url = {https://europepmc.org/article/PMC/PMC13701945},
note = {CC BY},
}
RIS
TY - JOUR
TI - The Gut–Kidney Axis in Chronic Kidney Disease: Microbial Dysbiosis, Host–Microbial Metabolism, and Emerging Therapeutic Strategies
AU - Louise Vijverman
AU - Too Maddalena
AU - Charlotte Delrue
AU - Marijn M. Speeckaert
PY - 2026
DA - 2026/09/22
JO - Biomedicines
UR - https://europepmc.org/article/PMC/PMC13701945
SN - 2227-9059
ER -